| Literature DB >> 35388342 |
Ann E Caldwell1,2, Sarah A Purcell1,2, Bethany Gray2, Hailey Smieja2, Victoria A Catenacci1,2.
Abstract
Background: Yoga may reduce body weight in individuals with overweight or obesity, but whether this occurs through decreased energy intake (EI) or increased energy expenditure (EE)/physical activity (PA) is unclear.Entities:
Keywords: diet; energy metabolism; exercise; yogic
Year: 2021 PMID: 35388342 PMCID: PMC8976548 DOI: 10.1002/osp4.552
Source DB: PubMed Journal: Obes Sci Pract ISSN: 2055-2238
FIGURE 1Flow chart of eligible and included publications. PA, Physical activity [Correction added on 28 August 2021, after first online publication: Figure 1 has been updated]
Descriptions of included studies and results for dietary intake and physical activity
| First author, year | Study design | Intervention | Control | Population | Outcomes | Results | |
|---|---|---|---|---|---|---|---|
| Dietary intake | Physical activity | ||||||
| Braun et al. | Pre‐post | 5 days intensive workshop with Kripalu yoga methods (self‐acceptance, relaxation, | N/A |
| EI: Modified nutrition subscale (breakfast frequency, low‐fat, fruit, vegetable intake) |
↑ in nutrition score after 5‐days program (2.71 ± 0.66, 3.25 ± 0.64, ↑ in nutrition score after 12‐weeks (2.82 ± 0.56; 3.14 ± 0.47, |
↑ in PA score after 5‐days program (2.19 ± 0.73; 2.61 ± 0.77, ↔ in PA score after 12 weeks (2.20 ± 0.71, 3‐months: 2.31 ± 0.85, |
|
| PA: Subscale, both from the health‐Promoting lifestyle Profile II | ||||||
| Cohen et al. | Randomized controlled trial | 10 weeks of restorative yoga; 3‐hour introductory class, 90‐minute class 2×/week (weeks 1–5), 1×/week (weeks 6–10) in‐person | No intervention control |
| Total EI, % EI from carbohydrate, fat, and protein via 2005 Block FFQ (macronutrient results not presented) | ↔ in EI ∆ between groups (yoga: 233 ± 1462; control: 154 ± 546, | ↔ ∆ between groups in hours/week (yoga: 2.0 ± 9.1; control: 1.6 ± 3.9, |
|
|
| PA in hours/week and METs/week using the modified CHAMPS PA questionnaire | |||||
| Jakicic et al. | Randomized controlled trial | 24 weeks of either restorative or Vinyasa yoga; 5×/week, building from 20 to 60 minutes with one in‐person and four at home classes + EI restriction of 1200 to 1800 kcal/day + weekly behavioral weight loss lessons | Comparison group (not control) ‐ “Hatha Restorative” yoga |
| Total EI, % EI from carbohydrate, fat, and protein via diet history questionnaire (food frequency) | In both groups: ↓ in EI, kcal/day: Vinyasa: Baseline: 1471 (95% CI: 1084–1858), 6 months: 1054 (750–1359); restorative: 1503 (1076–1930), 1092 (788–1396); ↓ fat, % EI: Vinyasa: 36.3 (32.8–39.2), 29.6 (26.6–32.8); restorative: 36.0 (32.8–39.2), 31.9 (28.9–35.0); ↑ carbohydrate, % EI: Vinyasa: 49.0 (44.9–53.1), 54.8 (50.4–59.2); restorative: 48.6 (44.5–53.8), 50.6 (46.4–54.8); ↑ eating behavior Inventory: Vinyasa: 54.9 (51.2–58.6), 66.6 (62.7–70.5); restorative: 54.5 (50.6–58.3), 64.8 (61.0–68.6); | ↑ PA in both groups and was greater in restorative yoga group: PA, kcal/week: Vinyasa: 596 (403–789), 831 (498–1164); restorative: 585 (387–783), 1189 (857–1521), PA, kcal/week, without stairs: Vinyasa: 322 (145–500), 489 (179–800); restorative: 292 (110–475), 877 (568–1186), PA min/week, without stairs: Vinyasa: 57 (81–93), 102 (35–169); restorative: 52 (15–88), 192 (125–260), |
| In Vinyasa: | n = 25 randomized, n = 20 completed | Eating behavior Inventory | |||||
| PA in kcal/week with or without flights of stairs and min/week without flights of stairs via validated questionnaire (not specified) | |||||||
| Littman et al. | Randomized controlled trial | 24 weeks of Hatha‐based yoga for people with obesity; 5×/week, with 1 to 3, 75 minutes in‐person sessions; remaining sessions were 20 to 30 minutes at home | No intervention control |
| PA in MET‐hours/week via self‐administered version of the Modifiable activity Questionnaire | N/A |
↑ in MET‐hours/week of total PA in yoga group: pre: 15.1 ± 11.7, post: 19.2 ± 19.1; control: 12.4 ± 12.8, 12.1 ± 13.6; no ↑ in MET‐hours/week for non‐yoga PA: yoga: 15.0 ± 11.6, 16.9 ± 18.9; control: 12.4 ± 11.8; 12.0 13.6; no |
|
|
| ||||||
| Mama et al. | Randomized controlled trial | 8 weeks of culturally adapted movement‐based mind‐body intervention; 4×/week, with two 45 minutes in‐person sessions and two at‐home sessions (unspecified duration). | Waitlist control |
| Walking, moderate, vigorous, and total MET‐minutes/week from +MVPA in min/day via IPAQ‐long form | N/A |
↑ in MET min/week: yoga: walking (2620), moderate (2371), vigorous (3153) total (8144) PA and MVPA in min/day (141); control: Walking (869), moderate (453), vigorous (57) PA and MVPA in min/day (17); no ↔ MVPA from accelerometer: yoga: −2 minutes/day; control: 0 minutes/day; no |
|
|
| MVPA in min/day from accelerometry (waist‐worn Actigraph GT3X) | |||||
| Ruby et al. | Randomized controlled trial | 12 weeks consisting of 1 week of baseline testing and 11 weeks of yoga |
Resistance training, three, ≤1‐hour sessions/week in conjunction with protein pacing diet (2) Protein pacing diet only |
| Total EI, % EI from carbohydrate, fat, and protein, saturated fat, cholesterol, iron, glycemic index via 3 days food records | ↔ in dietary parameters (change in values not presented) | N/A |
|
|
| ||||||
| Siu et al. | Randomized controlled trial | 1 year intervention consisting of three, 1‐hour instructor‐led Hatha‐based yoga sessions/week including | No‐intervention control; subjects were contacted monthly to assess their health status |
| EI, carbohydrate, fat, protein, fiber, soluble fiber, sugar, and cholesterol via 3 days food records | ↔ in dietary parameters: EI, kcal/day change: yoga: 64 ± 880; control: −126 ± 599, Carbohydrate, g/day: yoga: pre: 362 ± 148, post: 363 ± 177; control: 341 ± 148, 397 ± 426, Fat, g/day: yoga: 74 ± 118, 50 ± 21; control: 61 ± 71, 61 ± 73, Protein, g/day: yoga: 118 ± 62, 109 ± 45; control: 104 ± 45, 109 ± 76, |
Total PA, MET‐minutes/week: yoga: 458 ± 2841; control: 358 ± 3598; no Sitting, min/week: yoga: −200 ± 1192; control: −348 ± 1560; no |
|
|
| PA in MET‐minutes/week via IPAQ | |||||
| Telles et al. | Pre‐post | 12‐weeks intervention with three, 75‐minute in‐person sessions/week including | Nutrition advice group; received 1.45‐minutes nutrition lecture/week and same diet plan as yoga group |
| EI, carbohydrate, fat, and protein (g/day) via 24‐hour diet recall; “eating behaviour” via Moorehead‐Ardelt quality of life Questionnaire | ↔ in dietary parameters between groups (no EI, kcal/day: yoga: 1754 ± 424, 1591 ± 366; control: 1626 ± 395, 1716 ± 385 Carbohydrate, g/day: yoga: 217 ± 55, 249 ± 114; control: 194 ± 77, 222 ± 78 Fat, g/day: 39 ± 14, 41 ± 17; control: 48 ± 20, 47 ± 19 Protein, g/day yoga: pre: 59 ± 14, post: 51 ± 10; control: 54 ± 17, 56 ± 10 ↑ focus on eating behavior in yoga group: yoga: 0.2 ± 0.3, 0.3 ± 1.9; control: 0.3 ± 0.2, 0.3 ± 0.2 | N/A |
| Yadav et al. | Randomized controlled trial | 12‐weeks intervention, | Diet‐only group |
| EI; % EI from carbohydrate, fat, and protein; fiber (g/day) via 24‐hour diet recalls |
↓ EI, kcal/day: yoga: 400 (95% CI: −506, −295), ↑ carbohydrate, % EI: yoga: 2.0 (0.9, 3.2), ↓ fat, % EI: yoga: −2.9 (−4.0, −1.8), ↑ protein, % EI: yoga: 1.5 (1.1, 1.8), |
|
| 5×/week; first 2 weeks in‐person (∼2 hours), remaining 10 weeks at‐home + Tailored diet plan from a registered dietician |
| PA in MET‐minutes/week via IPAQ‐short form | ↑ PA, in MET min/week: yoga: 857 (189, 1658), | ||||
|
| |||||||
| Yazdanparast et al. | Randomized controlled trial | 8‐weeks intervention, with Hatha yoga (∼200 kcal energy expenditure) + 300 kcal/day EI restriction (yoga + diet) | Diet‐only intervention: 500 kcal/day EI restriction |
| RMR: Desktop indirect calorimeter (FitMate PRO) | N/A |
|
| 7×/week; 5×/week 60‐minute in‐person, 2×/week at‐home |
| RMR, kcal/day: yoga: 95 ± 105; control: 0 ± 110, | |||||
|
| |||||||
Notes: ∆: change; ↑: increase; ↓ decrease; ↔: no difference.
Abbreviations: BMI, body mass index; CHAMPS, Community Health Activities Model Program for Seniors; EI, energy intake; FFQ, food frequency questionnaire; in, kg/m2; IPAQ, International Physical Activity Questionnaire; MET, metabolic equivalency of tasks; PA, physical activity.
Energy intake and macronutrients reported for brevity (no micronutrients).
National Cholesterol Education Program criteria, defined as three or more of the following indicators: fasting blood sugar ≥100 mg/dL; systolic blood pressure ≥130 mmHg, diastolic blood pressure ≥85 mmHg, or use of antihypertensive medication; high density lipoprotein cholesterol (HDL‐C) ≤40 mg/dL for men or ≤50 mg/dL for women; triglycerides ≥150 mg/dL; and waist circumference ≥102 cm for men or ≥90 cm for women.
Telles et al. described food records as “weighed dietary records”; however, because no additional information on weighing methods or diet data analysis were provided, we assumed this was a 3‐days diet record without food weighing.
The IPAQ was administered, but MET‐minutes or MET‐hours per week were not reported and only used to calculate estimated total daily energy expenditure and thus results are not included.
Joint Interim Statement criteria, defined as three or more of the following indicators: fasting blood sugar ≥100 mg/dL, systolic blood pressure ≥130 mmHg, and/or diastolic blood pressure ≥85 mmHg, or use of antihypertensive medication; HDL‐C <40 mg/dL for men or <50 mg/dL for women; triglycerides ≥150 mg/dL; and waist circumference ≥90 cm for men or ≥80 cm for women (for Asians).
Risk of bias of included studies
| Study | Question | Risk of bias | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | ||
| Pre‐post design | |||||||||||||||
| Braun et al. | Y | Y | N | NR | NR | N | N | CD | N | CD | N | NA | – | – | High |
| Telles et al. | Y | Y | Y | NR | Y | Y | Y | Y | NR | N | N | NA | – | – | Moderate |
| Controlled interventions | |||||||||||||||
| Cohen et al. | Y | Y | Y | NA | NR | CD | Y | Y | Y | Y | Y | NA | Y | N | Low |
| Jakicic et al. | Y | Y | Y | NA | NR | CD | Y | Y | N | NR | Y | NA | Y | Y | Moderate |
| Littman et al. | Y | Y | CD | NA | NR | Y | Y | Y | Y | NR | Y | NA | Y | N | Low |
| Mama et al. | Y | NR | CD | NA | NR | Y | Y | N | N | NR | Y | NA | Y | N | Moderate |
| Ruby et al. | Y | CD | NR | NA | NR | CD | N | N | NR | NR | Y | N | Y | Y | Moderate |
| Siu et al. | Y | Y | Y | NA | NR | Y | N | Y | NR | NR | Y | Y | Y | N | Moderate |
| Yadav et al. | Y | Y | Y | NA | Y | Y | N | Y | NR | NR | Y | Y | Y | Y | Low |
| Yazdanparast et al. | Y | Y | Y | NA | NR | Y | Y | Y | NR | NR | Y | Y | Y | N | Moderate |
Notes: Questions are from the National Institutes of Health (NIH) Quality Assessment Tool for Before‐After (Pre‐Post) Studies with No Control Group and the NIH Quality Assessment of Controlled Intervention Studies (listed below). Each cell represents an assessment of each study, based on review and consensus from two reviewers (A.C. and S.P) as follows: Y, yes; N, no; CD, cannot determine; NA, not applicable; NR, not reported.
Pre‐post:1. Was the research question or objective clearly stated?2. Were the eligibility/selection criteria for the study population prespecified and clearly described?3. Were the participants in the study representative of those who would be eligible for the test/service/intervention in the general or clinical population of interest?4. Were all eligible participants that met the prespecified entry criteria enrolled?5. Was the sample size sufficiently large to provide confidence in the findings?6. Was the test/service/intervention clearly described and delivered consistently across the study population?7. Were the outcome measures prespecified, clearly defined, valid, reliable, and assessed consistently across all study participants?8. Were the people assessing the outcomes blinded to the participants' exposures/interventions?9. Was the loss to follow‐up after baseline 20% or less? Were those lost to follow‐up accounted for in the analysis?10. Did the statistical methods examine changes in outcome measures from before to after the intervention? Were statistical tests done that provided p‐values for the pre‐to‐post changes?11. Were outcome measures of interest taken multiple times before the intervention and multiple times after the intervention (i.e., did they use an interrupted time‐series design)?12. If the intervention was conducted at a group level (e.g., a whole hospital, a community, etc.) did the statistical analysis take into account the use of individual‐level data to determine effects at the group level?
Controlled Trials: 1. Was the study described as randomized, a randomized trial, a randomized clinical trial, or an RCT?2. Was the method of randomization adequate (i.e., use of randomly generated assignment)?3. Was the treatment allocation concealed (so that assignments could not be predicted)?4. Were study participants and providers blinded to treatment group assignment?5. Were the people assessing the outcomes blinded to the participants’ group assignments?6. Were the groups similar at baseline on important characteristics that could affect outcomes (e.g., demographics, risk factors, and co‐morbid conditions)?7. Was the overall drop‐out rate from the study at endpoint 20% or lower of the number allocated to treatment?8. Was the differential drop‐out rate (between treatment groups) at endpoint 15 percentage points or lower?9. Was there high adherence to the intervention protocols for each treatment group?10. Were other interventions avoided or similar in the groups (e.g., similar background treatments)?11. Were outcomes assessed using valid and reliable measures, implemented consistently across all study participants?12. Did the authors report that the sample size was sufficiently large to be able to detect a difference in the main outcome between groups with at least 80% power?13. Were outcomes reported or subgroups analyzed prespecified (i.e., identified before analyses were conducted)?14. Were all randomized participants analyzed in the group to which they were originally assigned, that is, did they use an intention‐to‐treat analysis?